The New Paper

April 26, 2021

CDC and FDA lift pause recommendation for Johnson and Johnson vaccine

The CDC and FDA lifted their recommended pause on Johnson & Johnson’s coronavirus vaccine, finding that the vaccine is safe and effective in preventing the virus and that the benefits outweigh the risks. The agencies initially recommended the pause after six reported cases of blood clots (out of ~7M doses administered).
This story is from the April 26, 2021 edition of The New Paper – a clear, concise daily briefing that makes fact-first news easy to consume. Try it today.